New insights into the role of gender in breast cancer development (eg. BRCA2)

New insights 

 One of the most interesting findings was that MBCs diagnosed in BRCA2 mutation carriers were more likely to be of a higher grade at younger ages than breast cancers diagnosed in men from the general population. Why having a mutation in BRCA2 would differ in the presentation between MBC and FBC is a mystery.